If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,994.00
Bid: 2,004.00
Ask: 2,006.00
Change: 13.00 (0.66%)
Spread: 2.00 (0.10%)
Open: 1,987.00
High: 2,008.00
Low: 1,979.00
Prev. Close: 1,981.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks rise amid raft of solid earnings

Thu, 22nd Feb 2024 16:26

(Sharecast News) - London's stock markets finished in positive territory on Thursday, bolstered by upbeat performances from US AI chipmaker Nvidia and engine manufacturer Rolls-Royce.

The FTSE 100 index rose 0.29% to reach 7,684.49 points, while the FTSE 250 climbed 0.76% to settle at 19,263.50 points.

In currency markets, sterling was last up 0.01% on the dollar to trade at $1.2639, while the euro saw a slight increase of 0.03% to last change hands at €1.1685.

"Risk on sentiment following another set of bumper Nvidia earnings helped the Nikkei 225 overcome its 1989 peak and hit record highs, as did the French and German blue chip indices," said IG senior market analyst Axel Rudolph.

"They did so despite ECB officials agreeing that it is premature to talk about rate cuts and as the German PMI data showed that the economic downturn deepened.

"The French services sector contraction eased markedly, though, as did the eurozone private sector downturn which, although showing a ninth consecutive month of falling output, saw the weakest contraction since last June, as output stabilisation in the service sector offset a further steep downturn in manufacturing."

Rudolph added that Nvidia's 12% gains, and its Nasdaq 100 weighting, had pushed the index up by around 2% as risk-on sentiment returned.

"The near three-month rise in the US Treasury yield to 4.35% and much weaker-than-expected initial jobless claims haven't dampened the mood.

"The dollar reversed its initial post-FOMC minutes weakness on Thursday afternoon, putting an end to gold's six straight days of gains."

UK private sector activity jumps in February

In economic news, private-sector activity in the UK surged to a nine-month peak in February, driven by robust growth in the service sector, compensating for ongoing weaknesses in manufacturing.

The S&P Global/CIPS composite purchasing managers' index (PMI), a key indicator of economic activity encompassing both services and manufacturing, climbed to 53.3, surprising analysts who had anticipated no change from January's level of 52.9.

It marked the fourth consecutive month of expansion, denoted by any figure above 50, and the strongest reading since May last year.

S&P Global noted a significant uptick in customer demand, with the sharpest increase in new work in nine months.

Moreover, optimism about near-term business prospects reached its highest level since February 2022.

Although the services PMI remained steady at 54.3, surpassing the consensus estimate of 54.1, the manufacturing PMI rose slightly to 47.1 from 47.0, albeit missing economists' forecast of 47.5.

"UK economic growth has accelerated in February, with the early PMI survey data pointing to the largest rise in business activity for nine months," said Chris Williamson, chief business economist at S&P Global Market Intelligence.

"This is by no means a one-off improvement, as faster growth has now been recorded for four straight months after a brief spell of decline late last year.

"It's particularly encouraging to see that the upturn in growth has been accompanied by a surge in optimism about year-ahead prospects to the highest for two years, in turn encouraging a second month of increased employment."

In the eurozone, the downturn in the services sector exhibited signs of abating, while manufacturing remained sluggish, as per a closely monitored survey released on Thursday.

The HCOB PMI indicated that business activity in the euro area contracted at a slower pace in February, with the flash eurozone composite output index reaching 48.9, the highest in eight months.

Notably, the services PMI hit the pivotal 50 mark, indicating growth, and marked its best reading in seven months, rising from 48.4 in January.

Conversely, manufacturing slipped to 46.1 from 46.6, a two-month low.

Elsewhere, eurozone inflation dipped marginally last month, in line with expectations, according to data from Eurostat.

Annual inflation stood at 2.8% in January, down from December's 2.9%, aligning with both the initial estimate and consensus. A year earlier, inflation was recorded at 8.6%.

Across the broader EU bloc, inflation moderated to 3.1% in January from 3.4% in December.

Across the Atlantic, US private-sector activity growth eased slightly in February, revealed figures from S&P Global.

The composite purchasing managers' index (PMI) dipped to 51.4 this month, down from January's 52.0.

It still, however, remained the second-fastest rate of expansion since July 2023.

While the services PMI declined to 51.3 from 52.5, missing economists' expectations of 52.0, it signalled growth for the 13th consecutive month.

Conversely, the manufacturing PMI unexpectedly rose to a 17-month high of 51.5 from 50.7, surpassing the consensus forecast of 50.5, driven by increased production amid supply chain improvements following adverse weather conditions in January.

Rolls-Royce rises on results, WPP falls back

On London's equity markets, Rolls-Royce Holdings jumped 9.32% after reporting a remarkable increase in full-year profits for 2023, primarily driven by its civil aerospace segment.

The company's underlying operating profit more than doubled to £1.6bn, surpassing analyst expectations, with revenues climbing to £15.4bn.

Beazley surged by 8.93% after it upgraded its guidance for 2023, citing better-than-expected claims experience throughout the year.

Shareholders could also anticipate an additional capital return of around $300m along with the ordinary dividend.

Hikma Pharmaceuticals rose 4.28% following a nearly one-third increase in its dividend, attributed to double-digit growth in full-year core revenues and profits in 2023.

Lloyds Banking Group rebounded by 5.21% after reporting a 57% jump in full-year profits and announcing a £2bn share buyback.

However, the company set aside £450m for a regulatory probe into UK motor financing.

Anglo American saw a 3.03% increase despite halving its annual dividend due to profit declines in 2023, driven by impairments and market downturns in platinum and diamond sectors.

Mondi advanced by 1.8% despite reporting lower full-year profits due to weakened demand and prices, extending into the first quarter of 2024.

ME Group International surged by 20.03% on the back of record financial performance for the 12 months ended 31 October, with both revenues and profits witnessing growth.

Indivior spiked by 22.42% as the opioid addiction treatment maker deliberated on moving its primary listing to the US, while Jupiter Fund Management climbed by 10.67%, driven by a 36% rise in full-year underlying pre-tax profit.

On the downside, WPP declined by 6.38% despite meeting full-year expectations, while Hargreaves Lansdown dropped by 7.23% following a decline in net new business.

Safestore Holdings experienced a 3.7% decrease as quarterly revenues declined amid challenging economic conditions in the self-storage group sector.

Reporting by Josh White for Sharecast.com.

Market Movers

FTSE 100 (UKX) 7,684.49 0.29%

FTSE 250 (MCX) 19,263.50 0.76%

techMARK (TASX) 4,395.06 0.90%

FTSE 100 - Risers

Beazley (BEZ) 634.00p 8.93%

Rolls-Royce Holdings (RR.) 356.80p 8.29%

Lloyds Banking Group (LLOY) 45.95p 6.16%

Scottish Mortgage Inv Trust (SMT) 797.00p 4.51%

Hikma Pharmaceuticals (HIK) 2,083.00p 4.28%

Intertek Group (ITRK) 4,639.00p 3.60%

Rightmove (RMV) 550.80p 3.42%

Sage Group (SGE) 1,212.00p 3.19%

Anglo American (AAL) 1,769.80p 3.03%

Ashtead Group (AHT) 5,524.00p 2.64%

FTSE 100 - Fallers

WPP (WPP) 730.60p -6.38%

Endeavour Mining (EDV) 1,256.00p -4.73%

Tesco (TSCO) 276.80p -3.05%

Land Securities Group (LAND) 629.60p -2.51%

Sainsbury (J) (SBRY) 254.10p -2.01%

SSE (SSE) 1,578.00p -1.96%

Glencore (GLEN) 379.90p -1.59%

Marks & Spencer Group (MKS) 239.20p -1.52%

Unilever (ULVR) 4,000.00p -1.34%

Severn Trent (SVT) 2,539.00p -1.32%

FTSE 250 - Risers

Indivior (INDV) 1,660.00p 22.42%

Me Group International (MEGP) 159.40p 20.03%

Jupiter Fund Management (JUP) 90.75p 10.67%

Close Brothers Group (CBG) 347.80p 7.54%

Lancashire Holdings Limited (LRE) 652.00p 5.50%

Carnival (CCL) 1,107.00p 4.93%

Moneysupermarket.com Group (MONY) 251.80p 4.57%

Wizz Air Holdings (WIZZ) 2,191.00p 4.47%

FDM Group (Holdings) (FDM) 418.00p 4.37%

Bank of Georgia Group (BGEO) 4,570.00p 4.22%

FTSE 250 - Fallers

Hargreaves Lansdown (HL.) 747.20p -7.23%

Tullow Oil (TLW) 28.50p -5.25%

W.A.G Payment Solutions (WPS) 82.40p -4.63%

Safestore Holdings (SAFE) 767.00p -3.70%

Domino's Pizza Group (DOM) 367.20p -3.22%

Victrex plc (VCT) 1,280.00p -3.10%

BBGI Global Infrastructure S.A. NPV (DI) (BBGI) 122.40p -3.01%

PZ Cussons (PZC) 100.40p -2.52%

British Land Company (BLND) 360.60p -2.38%

IP Group (IPO) 49.00p -2.20%

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.